MoneyWorks4Me

Medicamen Biotech informs about Board Meeting

28 Mar 2014 Evaluate

Medicamen Biotech has informed that a meeting of the Board of Directors of the Company will be held on March 31, 2014, inter alia, to consider the Preferential Allotment of Equity Shares & Warrants convertible into Equity Shares to the promoter group.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1760.60
Dr. Reddys Labs. 1220.75
Cipla 1333.70
Lupin 1959.20
Zydus Lifesciences 1140.75
View more..